PC
IMMU

Polar Capital’s Immunomedics Inc IMMU Stock Holding History

Polar Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$21.7M Sell
255,632
-1,447,708
-85% -$73.2M 0.16% 126
2020
Q2 		$60.4M Buy
+1,703,340
New +$49.8M 0.52% 58
2019
Q1 		– Sell
-904,416
Closed -$12.9M – 298
2018
Q4 		$12.9M Buy
+904,416
New +$18M 0.14% 159

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Polar Capital's IMMU Position: Q3 2020 in Review

Polar Capital reduced its Immunomedics Inc (IMMU) stake by 85% in Q3 2020, selling an estimated $73.2M and leaving 255,632 shares worth $21.7M. The position accounts for 0.16% of the portfolio, ranked #126.

Polar Capital first reported a position in IMMU in Q4 2018 and has held it in 3 quarters since. The position peaked at $60.4M in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Polar Capital held 255,632 shares of Immunomedics Inc worth $21.7M as of Q3 2020.
  • Polar Capital sold 1,447,708 Immunomedics Inc shares in Q3 2020, an estimated $73.2M.
  • Immunomedics Inc made up 0.16% of Polar Capital's portfolio in Q3 2020, its #126 holding.
  • Polar Capital first reported a position in Immunomedics Inc in Q4 2018 and has held it in 3 quarters since.
  • Polar Capital's Immunomedics Inc position peaked at $60.4M in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.